{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:42:07Z","timestamp":1791214927945,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.neuropharm.2011.08.050","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T08:45:27Z","timestamp":1316508327000},"page":"843-854","source":"Crossref","is-referenced-by-count":139,"title":["Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: Descending monoamine system and opioid receptors are differentially involved"],"prefix":"10.1016","volume":"62","author":[{"given":"Xin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.08.050_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0304-3959(88)90198-4","article-title":"Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain","volume":"33","author":"Arn\u00e9r","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2011.08.050_bib2","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/gut.2009.186528","article-title":"Curcumin improves sclerosing cholangitis in Mdr2\u2212\/\u2212 mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation","volume":"59","author":"Baghdasaryan","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2011.08.050_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejpain.2003.09.002","article-title":"Role of spinal 5-HT1A receptors in morphine analgesia and tolerance in rats","volume":"8","author":"Bardin","year":"2004","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2011.08.050_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0014-2999(01)01029-9","article-title":"In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia","volume":"421","author":"Bardin","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2174\/157488909789104794","article-title":"From antidepressant drugs to beta-mimetics: preclinical insights on potential new treatments for neuropathic pain","volume":"4","author":"Barrot","year":"2009","journal-title":"Recent Pat. C.N.S Drug Discov."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2217\/fnl.09.82","article-title":"Antidepressant treatment of neuropathic pain: looking for the mechanism","volume":"5","author":"Barrot","year":"2010","journal-title":"Future Neurol."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib8","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ejpain.2008.01.010","article-title":"Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice","volume":"12","author":"Benbouzid","year":"2008","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2011.08.050_bib9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.biopsych.2007.06.016","article-title":"Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia","volume":"63","author":"Benbouzid","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.08.050_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A\u00a0peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2011.08.050_bib11","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ejpain.2009.11.014","article-title":"Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia","volume":"14","author":"Bohren","year":"2010","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2011.08.050_bib12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuropharm.2004.09.012","article-title":"Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain","volume":"48","author":"Bomholt","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.050_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/bja\/87.1.12","article-title":"Mechanisms of neuropathic pain","volume":"87","author":"Bridges","year":"2001","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/157488910791213158","article-title":"Herbals and natural dietary supplements in psychiatric practice","volume":"5","author":"Chiappedi","year":"2010","journal-title":"Recent Pat. C.N.S Drug Discov."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib15","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1476-5381.2009.00510.x","article-title":"Beta2-adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment","volume":"158","author":"Choucair-Jaafar","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0028-3908(02)00119-3","article-title":"Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia","volume":"43","author":"Colpaert","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.050_bib17","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1001\/jama.293.24.3043","article-title":"Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials","volume":"293","author":"Eisenberg","year":"2005","journal-title":"J.A.M.A"},{"key":"10.1016\/j.neuropharm.2011.08.050_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: an evidence based proposal","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2011.08.050_bib19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-8993(03)03324-9","article-title":"Effects of neurotoxic destruction of descending noradrenergic pathways on cannabinoid antinociception in models of acute and tonic nociception","volume":"987","author":"Gutierrez","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1476-5381.1957.tb01354.x","article-title":"Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse","volume":"12","author":"Haley","year":"1957","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.nrl.0000155180.60057.8e","article-title":"Chronic neuropathic pain. Mechanisms, diagnosis, and treatment","volume":"11","author":"Harden","year":"2005","journal-title":"Neurologist"},{"key":"10.1016\/j.neuropharm.2011.08.050_bib22","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.neuropharm.2006.05.031","article-title":"Fluvoxamine, a selective serotonin reuptake inhibitor, exerts its anti-allodynic effects on neuropathic pain in mice via 5-HT2A\/2C receptors","volume":"51","author":"Honda","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.050_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1533-2500.2006.00055.x","article-title":"Pharmacotherapy for neuropathic pain","volume":"6","author":"Jackson","year":"2006","journal-title":"Pain Pract."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3122\/jabfm.2010.03.080252","article-title":"Perceived benefit of Complementary and Alternative Medicine (CAM) for back pain: a national survey","volume":"23","author":"Kanodia","year":"2010","journal-title":"J.\u00a0Am. Board Fam. Med."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00213-008-1300-y","article-title":"Antidepressant activity of curcumin: involvement of serotonin and dopamine system","volume":"201","author":"Kulkarni","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.08.050_bib27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.brainres.2007.05.049","article-title":"Relative contribution of peripheral versus central opioid receptors to antinociception","volume":"1160","author":"Labuz","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib28","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/labinvest.2009.115","article-title":"Curcumin attenuates the effects of insulin on stimulating hepatic stellate cell activation by interrupting insulin signaling and attenuating oxidative stress","volume":"89","author":"Lin","year":"2009","journal-title":"Lab. Invest."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/jpet.103.052613","article-title":"Evidence for an involvement of supraspinal delta- and spinal mu-opioid receptors in the antihyperalgesic effect of chronically administered clomipramine in mononeuropathic rats","volume":"307","author":"Marchand","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib30","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.tips.2006.05.004","article-title":"Antidepressants and pain","volume":"27","author":"Mic\u00f3","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","article-title":"Descending control of pain","volume":"66","author":"Millan","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ptr.2662","article-title":"Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat","volume":"23","author":"Mittal","year":"2009","journal-title":"Phytother. Res."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neulet.2005.01.079","article-title":"Noradrenergic receptor mRNA expression in adult rat superficial dorsal horn and dorsal root ganglion neurons","volume":"380","author":"Nicholson","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejphar.2006.09.029","article-title":"Possible involvement of opioidergic systems in the anti-nociceptive effect of the selective serotonin reuptake inhibitors in sciatic nerve-injured mice","volume":"552","author":"Nozaki","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canlet.2004.01.008","article-title":"Induction of apoptosis in human lung cancer cells by curcumin","volume":"208","author":"Radhakrishna","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2010.07.022","article-title":"Curcumin ameliorates cognitive dysfunction and oxidative damage in phenobarbitone and carbamazepine administered rats","volume":"644","author":"Reeta","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib37","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.cell.2009.04.019","article-title":"Dissociation of the opioid receptor mechanisms that control mechanical and heat pain","volume":"137","author":"Scherrer","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2011.08.050_bib38","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejphar.2006.03.006","article-title":"Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain","volume":"536","author":"Sharma","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1196\/annals.1352.010","article-title":"Curcumin: getting back to the roots","volume":"1056","author":"Shishodia","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib40","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1213\/01.ANE.0000160582.25368.B9","article-title":"The anti-allodynic and antihyperalgesic effects of neurotropin in mice with spinal nerve ligation","volume":"101","author":"Suzuki","year":"2005","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib41","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1213\/ane.0b013e318167889a","article-title":"Anti-allodynic and antihyperalgesic effect of milnacipran in mice with spinal nerve ligation","volume":"106","author":"Suzuki","year":"2008","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib42","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3923\/pjbs.2008.312.314","article-title":"The effect of curcumin (active substance of turmeric) on the acetic acid-induced visceral nociception in rats","volume":"11","author":"Tajik","year":"2008","journal-title":"Pak. J. Biol. Sci."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib43","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.neuropharm.2007.08.013","article-title":"Pregabalin, -(+)-3-isobutylgaba, activates the descending noradrenergic system to alleviate neuropathic pain in the mouse partial sciatic nerve ligation model","volume":"53","author":"Takeuchi","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.050_bib44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.bjp.0707125","article-title":"The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems","volume":"150","author":"Tanabe","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib45","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1523\/JNEUROSCI.23-02-00708.2003","article-title":"Absence of thermal hyperalgesia in serotonin transporter-deficient mice","volume":"23","author":"Vogel","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib46","first-page":"101","article-title":"The relationship between pain and depression","volume":"30","author":"Von","year":"1996","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pain.2009.03.013","article-title":"Non-steroidal anti-inflammatory drugs for neuropathic pain: how do we explain continued widespread use?","volume":"143","author":"Vo","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2011.08.050_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2007.08.045","article-title":"The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors","volume":"578","author":"Wang","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2007.05.071","article-title":"Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats","volume":"1162","author":"Xu","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2005.06.002","article-title":"The effects of curcumin on depressive-like behaviors in mice","volume":"518","author":"Xu","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib51","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.neuropharm.2009.06.010","article-title":"Curcumin reverses impaired cognition and neuronal plasticity induced by chronic stress","volume":"57","author":"Xu","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.050_bib52","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ana.21542","article-title":"Beta2-adrenoceptors are critical for antidepressant treatment of neuropathic pain","volume":"65","author":"Yalcin","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib53","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.nbd.2008.11.003","article-title":"Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain","volume":"33","author":"Yalcin","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib54","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/08923970500242244","article-title":"Immunomodulatory effects of curcumin","volume":"27","author":"Yadav","year":"2005","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib55","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/0022034509356169","article-title":"Curcumin produces an antihyperalgesic effect via antagonism of TRPV1","volume":"89","author":"Yeon","year":"2010","journal-title":"J.\u00a0Dent. Res."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib56","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1111\/j.1460-9568.2004.03810.x","article-title":"Blocking the R-type (Cav2.3) Ca2+ channel enhanced morphine analgesia and reduced morphine tolerance","volume":"20","author":"Yokoyama","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.050_bib57","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1358\/dot.2009.45.6.1385751","article-title":"Phytotherapy for pain relief","volume":"45","author":"Zareba","year":"2009","journal-title":"Drugs Today (Barc)"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811004072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811004072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T10:49:42Z","timestamp":1617619782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811004072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0028390811004072"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.08.050","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}